4-68930634-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_024743.4(UGT2A3):c.1216G>A(p.Ala406Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,613,454 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024743.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UGT2A3 | NM_024743.4 | c.1216G>A | p.Ala406Thr | missense_variant | 5/6 | ENST00000251566.9 | |
UGT2A3 | XM_011532247.3 | c.1234G>A | p.Ala412Thr | missense_variant | 5/6 | ||
UGT2A3 | XM_047416177.1 | c.349G>A | p.Ala117Thr | missense_variant | 5/6 | ||
UGT2A3 | NR_024010.2 | n.1357G>A | non_coding_transcript_exon_variant | 6/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UGT2A3 | ENST00000251566.9 | c.1216G>A | p.Ala406Thr | missense_variant | 5/6 | 1 | NM_024743.4 | P1 | |
UGT2A3 | ENST00000503012.1 | c.*392G>A | 3_prime_UTR_variant, NMD_transcript_variant | 6/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152034Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 250954Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135626
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461420Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727022
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152034Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74240
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2023 | The c.1216G>A (p.A406T) alteration is located in exon 5 (coding exon 5) of the UGT2A3 gene. This alteration results from a G to A substitution at nucleotide position 1216, causing the alanine (A) at amino acid position 406 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at